Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03478735 · ClinicalTrials.gov registry record · NA
Ultrasound Greater Occipital Nerve Block at C2 Level Compared to Landmark-based Greater Occipital Nerve Block
A NA study of Migraine Without Aura and Cervicogenic Headache, sponsored by Mayo Clinic.
- Completed
- Registry status
- NA
- Development phase
- 32
- Enrollment target
- 1
- Study location
NCT03478735 is a NA study of Migraine Without Aura and Cervicogenic Headache that has completed, run by Mayo Clinic. The registered enrollment target is 32 participants, below the 169-participant average among 6 other Migraine Without Aura trials with a reported enrollment target (81% lower). The trial reports 1 study location across 1 state.
The verdict
NCT03478735, a NA study of Migraine Without Aura and Cervicogenic Headache, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 32 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will compare the analgesic benefit of a traditional landmark-guided GON block with the ultrasound-guided approach over a four week period in patients with occipital neuralgia or cervicogenic headache.
Conditions Studied
Interventions
- PROCEDURE Ultrasound Guided Greater Occipital Nerve Block at C2
- PROCEDURE Landmark-Based Greater Occipital Nerve Block
Study Locations (1)
Minnesota
- Mayo Clinic in Rochester - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2017-07-17 |
| Est. Completion | 2021-06-14 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03478735
The ClinicalTrials.gov registry entry for NCT03478735 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 32 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 169-participant average among 6 other Migraine Without Aura trials with a reported enrollment target (81% lower). The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Migraine Without Aura appearing as the primary indexed condition, and to 2 interventions - of which Ultrasound Guided Greater Occipital Nerve Block at C2 is the first listed.
NCT03478735 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.
Frequently Asked Questions
What is clinical trial NCT03478735 about?
NCT03478735 is a clinical study titled "Ultrasound Greater Occipital Nerve Block at C2 Level Compared to Landmark-based Greater Occipital Nerve Block". This study will compare the analgesic benefit of a traditional landmark-guided GON block with the ultrasound-guided approach over a four week period in patients with occipital neuralgia or cervicogenic headache.
What is the current status of trial NCT03478735?
This trial is currently completed. It is a NA study. The enrollment target is 32 participants. The study started on 2017-07-17. Estimated completion is 2021-06-14.
What conditions does trial NCT03478735 study?
This clinical trial studies the following conditions: Migraine Without Aura, Cervicogenic Headache, Occipital Neuralgia.
What interventions are being tested in trial NCT03478735?
The interventions under investigation include: Ultrasound Guided Greater Occipital Nerve Block at C2 (PROCEDURE), Landmark-Based Greater Occipital Nerve Block (PROCEDURE).
Who is sponsoring clinical trial NCT03478735?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03478735 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Migraine Without Aura
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Responding With Evidence and Access for Childhood Headaches
RECRUITING · NA
-
Mind Body Balance for Pediatric Migraine
RECRUITING · NA
-
Integrative Migraine Pain Alleviation Through Chiropractic Therapy
COMPLETED · NA
-
Maxalt 10mg Plus Caffeine 75mg in the Acute Treatment of Migraine Headache
COMPLETED · Phase 3
-
Study of the Safety and Effectiveness of NXN-188 for the Treatment of Migraine Headache Without Aura
COMPLETED · Phase 2
-
A Phase I Study to Study the PK and Safety of Single Doses of STS101, DHE Injection and Nasal Spray in Healthy Subjects
COMPLETED · Phase 1
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.